blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1435387

EP1435387 - ONCOLYTIC ADENOVIRUS EXPRESSING HSP AND USES THEREOF [Right-click to bookmark this link]
Former [2004/28]THE ONCOLYTIC MICROORGANISMS EXPRESSING HSP AND USES THEREOF
[2009/49]
StatusThe application is deemed to be withdrawn
Status updated on  05.11.2010
Database last updated on 02.11.2024
Most recent event   Tooltip05.11.2010Application deemed to be withdrawnpublished on 08.12.2010  [2010/49]
Applicant(s)For all designated states
Hangzhou Conquer Biotech Co., Ltd.
199 Wensan Road Hangzhou
Zhejiang Province 310012 / CN
[N/P]
Former [2004/28]For all designated states
Hangzhou Conquer Biotech Co., Ltd.
199 Wensan Road
Hangzhou, Zhejiang Province 310012 / CH
Inventor(s)01 / CHEN, Siyi
3923 Abbeywood Drive
Pearland, TX 77584 / US
02 / HU, Fang
B7 Zaojunmiao, Haidian District
Beijing 100081 / CN
 [2004/28]
Representative(s)Zounek, Nikolai, et al
Plate Schweitzer Zounek Patentanwälte Rheingaustrasse 196
65203 Wiesbaden / DE
[2008/43]
Former [2008/29]Zounek, Nikolai, et al
Zounek Plate Schweitzer Rheingaustrasse 196
65203 Wiesbaden / DE
Former [2006/06]Zounek, Nikolai, et al
Zounek Plate Schweitzer Patentanwaltskanzlei Rheingaustrasse 196
65203 Wiesbaden / DE
Former [2004/28]Zounek, Nikolai, Dipl.-Ing., et al
Patentanwalt Zounek Postfach 3540
65174 Wiesbaden / DE
Application number, filing date01274525.312.12.2001
[2004/28]
WO2001CN01616
Priority number, dateCN200114169609.10.2001         Original published format: CN 01141696
[2004/28]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03031602
Date:17.04.2003
Language:EN
[2003/16]
Type: A1 Application with search report 
No.:EP1435387
Date:07.07.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 17.04.2003 takes the place of the publication of the European patent application.
[2004/28]
Search report(s)International search report - published on:CN17.04.2003
(Supplementary) European search report - dispatched on:EP18.11.2004
ClassificationIPC:A61K35/76, C12N15/861, A61K39/00, A61K38/17, A61K39/39
[2005/01]
CPC:
A61K35/74 (EP,US); A61K35/761 (EP,US); A61K35/763 (EP,US);
A61K38/1709 (EP,US); A61P13/08 (EP); A61P35/00 (EP);
A61P43/00 (EP); C12N2710/10343 (EP,US); C12N2710/16632 (EP,US);
Y02A50/30 (EP,US) (-)
C-Set:
A61K35/74, A61K2300/00 (US,EP);
A61K35/761, A61K2300/00 (US,EP);
A61K35/763, A61K2300/00 (US,EP);
A61K38/1709, A61K2300/00 (EP,US)
Former IPC [2004/28]C12N1/21
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/28]
Extension statesAL10.07.2003
LT10.07.2003
LV10.07.2003
MK10.07.2003
RO10.07.2003
SI10.07.2003
TitleGerman:HSP EXPRIMIERENDE ONKOLYTISCHE ADENOVIREN UND IHRE VERWENDUNGEN[2009/49]
English:ONCOLYTIC ADENOVIRUS EXPRESSING HSP AND USES THEREOF[2009/49]
French:ADÉNOVIRUS ONCOLYTIQUES EXPRIMANT LES PROTEINES HSP, ET LEURS UTILISATIONS[2009/49]
Former [2004/28]HSP EXPRIMIERENDE ONKOLYTISCHE MIKROORGANISMEN UND IHRE VERWENDUNGEN
Former [2004/28]THE ONCOLYTIC MICROORGANISMS EXPRESSING HSP AND USES THEREOF
Former [2004/28]MICRO-ORGANISMES ONCOLYTIQUES EXPRIMANT LES PROTEINES HSP, ET LEURS UTILISATIONS
Entry into regional phase10.07.2003Translation filed 
10.07.2003National basic fee paid 
10.07.2003Search fee paid 
10.07.2003Designation fee(s) paid 
10.07.2003Examination fee paid 
Examination procedure10.07.2003Examination requested  [2004/28]
05.10.2007Despatch of a communication from the examining division (Time limit: M04)
06.02.2008Reply to a communication from the examining division
29.09.2008Despatch of a communication from the examining division (Time limit: M04)
22.12.2008Reply to a communication from the examining division
02.02.2010Communication of intention to grant the patent
15.06.2010Application deemed to be withdrawn, date of legal effect  [2010/49]
20.07.2010Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2010/49]
Fees paidRenewal fee
16.10.2003Renewal fee patent year 03
14.12.2004Renewal fee patent year 04
15.12.2005Renewal fee patent year 05
13.12.2006Renewal fee patent year 06
12.12.2007Renewal fee patent year 07
05.01.2009Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.12.200909   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO9411513  (MEDICAL RES COUNCIL [GB], et al) [X] 1-3,5-10,27-35 * the whole document * [Y] 15,16,18,20-22;
 [X]WO9706685  (SLOAN KETTERING INST CANCER [US], et al) [X] 1-10,27-35 * the whole document *;
 [Y]  - C. L. SILVA ET AL., "Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC calss II in addition to MHC class I", MICROBIAL PATHOGENESIS, (1992), vol. 12, pages 27 - 38, XP002927135 [Y] 15,16,18,20-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/0882-4010(92)90063-T
 [XP]  - Y.S. HAVIV ET AL., "Heat shock and heat schock protein 70i enhance the oncolytic effect of replicative adenovirus", CANCER RESEARCH, (20011201), vol. 61, pages 8361 - 8365, XP002302194 [XP] 1-12,27-35 * page 8363, column 2, paragraph 3 *
 [A]  - S. TODRYK, "Heat shock protein 70 induced during tumour cell killing induces Th1 cytokines", J. IMMUNOL., (1999), vol. 163, pages 1398 - 1408, XP002302195 [A] 1 * the whole document *
International search[XP]WO0179548  (CORNELL RES FOUNDATION INC [US], et al);
 [X]WO0125399  (VION PHARMACEUTICALS INC [US], et al);
 [X]CA2300467  (DNAVEC RESEARCH INC [JP])
Examination   - YOON S.M. ET AL, "An oncolytic herpesvirus type 1 selectively destroys diffuse liver metastses from colon carcinoma", FASEB JOURNAL, (2000), vol. 14, pages 301 - 311, XP002972122
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.